Stonebridge Capital Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-121
| Closed | -$42.1K | – | 850 |
|
|
2023
Q3 | $42.1K | Hold |
121
| – | – | ﹤0.01% | 383 |
|
|
2023
Q2 | $42.6K | Buy |
+121
| New | +$42.6K | ﹤0.01% | 393 |
|
|
2023
Q1 | – | Sell |
-32
| Closed | -$9.24K | – | 1019 |
|
|
2022
Q4 | $9.24K | Sell |
32
-1
| -3% | -$289 | ﹤0.01% | 610 |
|
|
2022
Q3 | $10K | Sell |
33
-94
| -74% | -$28.5K | ﹤0.01% | 581 |
|
|
2022
Q2 | $36K | Hold |
127
| – | – | ﹤0.01% | 402 |
|
|
2022
Q1 | $33K | Hold |
127
| – | – | ﹤0.01% | 453 |
|
|
2021
Q4 | $28K | Hold |
127
| – | – | ﹤0.01% | 458 |
|
|
2021
Q3 | $23K | Hold |
127
| – | – | ﹤0.01% | 468 |
|
|
2021
Q2 | $26K | Buy |
+127
| New | +$26K | ﹤0.01% | 580 |
|
|
2020
Q1 | – | Sell |
-9
| Closed | -$2K | – | 868 |
|
|
2019
Q4 | $2K | Buy |
+9
| New | +$2K | ﹤0.01% | 756 |
|